ÂÜÀòÂÒÂ×

Andrew Groark

Associate Director, SEC Reporting and Technical Accounting at Fusion Pharmaceuticals

Andrew Groark has a diverse work experience in the accounting and financial industry. Andrew started their career as an Audit Staff at EY in 2013, progressing to Audit Senior and then to Audit Assistant Manager. Andrew later became an Audit Manager, responsible for managing auditing processes and teams. In 2019, they joined KSQ Therapeutics, Inc. as a Sr. Manager of Accounting. There, they utilized their expertise in financial reporting and accounting. In 2020, they moved to Fusion Pharmaceuticals, where they held the position of Sr. Manager of SEC Reporting and Technical Accounting. Andrew was recently promoted to the role of Associate Director in the same domain. Andrew's work experience demonstrates their strong knowledge and skills in financial reporting, accounting, and team management.

Andrew Groark attended the Isenberg School of Management at UMass Amherst from 2009 to 2013, where they earned a Bachelor of Business Administration degree with a major in Accounting. During the same time period, they also studied at the University of Massachusetts Amherst and obtained a Bachelor of Science degree in Psychology. In October 2014, Andrew Groark obtained their Certified Public Accountant (CPA) certification from the Massachusetts Board of Public Accountancy.

Links